Matches in Nanopublications for { ?s ?p "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP656504.RAYVKRlEvv-O9aOqB8kYD98voC9afEa26Dq0Lt19Muclk130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656504.RAYVKRlEvv-O9aOqB8kYD98voC9afEa26Dq0Lt19Muclk130_provenance.
- NP303206.RAror9iTSQyB073DxFahjreh7KR-OcPIq5Rpe4VL--1qE130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303206.RAror9iTSQyB073DxFahjreh7KR-OcPIq5Rpe4VL--1qE130_provenance.
- NP303300.RAnFMiWlyvlKsaHFRo3Eaa8gPRnmGcuAD4SGxRQnZbQOM130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303300.RAnFMiWlyvlKsaHFRo3Eaa8gPRnmGcuAD4SGxRQnZbQOM130_provenance.
- NP656502.RAtT2b2e_q_Aj0D8bUtNuareizeTSPCskch4TswqgqF5k130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656502.RAtT2b2e_q_Aj0D8bUtNuareizeTSPCskch4TswqgqF5k130_provenance.
- NP656506.RArC6rYn0BnVQT4Sz8a_DPRLNx15iVmI4i1AjrpzdSupQ130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656506.RArC6rYn0BnVQT4Sz8a_DPRLNx15iVmI4i1AjrpzdSupQ130_provenance.
- NP307936.RA9q-3XSqVFCqvEnv3HnTgMcqrF8Cz_m3-OCOgQ5hahUI130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307936.RA9q-3XSqVFCqvEnv3HnTgMcqrF8Cz_m3-OCOgQ5hahUI130_provenance.
- NP307983.RAFaA7VHhTvguXTWxiGqnMj_EGlSLfP9V1s-MIRAVztgs130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307983.RAFaA7VHhTvguXTWxiGqnMj_EGlSLfP9V1s-MIRAVztgs130_provenance.
- NP656505.RA1e0g2ZqxujggwQ6-B7TuTLIsj9yJ25Cny7suPEwGigY130_assertion description "[Inactivating mutations of CDKN1B, encoding the p27 cyclin-dependent kinase inhibitor, were reported to cause hyperparathyroidism in a multiple endocrine neoplasia type 1-like syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656505.RA1e0g2ZqxujggwQ6-B7TuTLIsj9yJ25Cny7suPEwGigY130_provenance.